Funding Forums

AdvaMed 2014 will feature four Funding Forums addressing critical issues in financing and growth in the medical technology industry.  Early-stage company executives and investors will benefit from these interactive discussions and gain insights into raising capital and forming strategic partnerships. Funding Forums at AdvaMed 2014 are co-located with Company Presentations and Sector MeetUps, providing a comprehensive business development program for early-stage companies, investors and corporate business development executives.


Corporate Business Development Forum

Tuesday, October 7
10:30 am – 11:15 am
Room: 181C

Strategic investments and M&A continue to be significant drivers of health care innovation. Corporate business development executives will discuss their approach to strategic investments and identify important elements of the due diligence process and key factors for successful deal making. This Forum will also include the perspective of a small company executive on developing partnerships and securing strategic investments.

Moderator:
Jon Salveson, Vice Chairman, Piper Jaffray & Co.

Panelists:
Edward Andrle, VP Strategy & Business Development, Sorin Group
Susan Morano, VP Business Development, Global Surgery Group, Johnson & Johnson
John Russell, Former President and CEO, Corventis (acquired by Medtronic)
 

Venture Capital Forum

Tuesday, October 7

3:30 pm – 4:15 pm
Room: 181A

Venture capital funding for medical devices declined 17 percent (in dollars) in 2013 and accounted for only seven percent of all venture capital funding in the U.S. Corporate venture investments are an increasingly important element of capital formation for MedTech companies, as uncertain regulatory and reimbursement conditions threaten already scarce venture capital. This Forum will discuss trends and new models in venture capital funding, and will provide guidance for early-stage companies on presenting a comprehensive value proposition to both corporate investors and traditional VCs.

Moderator:
Nicole Walker, Director, Venture Capital, Baird Capital

Panelists:
Mike Carusi, General Partners, Lightstone Ventures
Paul Grand, Managing Director, RCT Ventures
Anne Sissel, Partner, Baxter Ventures


Early-Stage Funding Forum

Wednesday, October 8
10:30 am – 11:15 am
Room: 181A

With limited venture capital for early-stage investments, MedTech start-ups must be creative in securing funding for their health care innovations. While angel investment remains an important source of capital, family funds, crowdfunding and philanthropic investments have emerged as viable—and often critical—options for early-stage MedTech investment. This Forum will assess how the crowdfunding model applies to our industry, and describe how entrepreneurs are working with foundations that fund medical research, as well as family funds and individual investors.

Moderator:
Randy Barko, President & CEO, Ximedica

Panelists:
Dennis Ford, Founder and CEO, Life Science Nation
Aaron Kowalski, Vice President, Artificial Pancreas, JDRF
Suzanne Reade, President, Chicago Arch Angels


Growth-Stage Funding Forum

Wednesday, October 8
10:30 am – 11:15 am
Room: 181C

While M&A is often the most likely exit strategy for growth-stage MedTech companies, the public markets have recently shown signs of opening to MedTech IPOs. This Forum will examine the impact on MedTech IPOs of reduced reporting requirements for qualifying Emerging Growth Companies, and address the steps growth-stage MedTech companies can take to manage the costs and complexity of an IPO. Against this backdrop, the panel will also assess the current landscape for M&A and the corporate business development perspective on deal-making with publicly listed and privately held MedTech companies.

Moderator:
Jon Hammack, Managing Director – Medical Technology, Moelis & Co.

Panelists:
Jeff Barton, Vice President, Licensing and Acquisitions, Abbott
Eric Major, Chief Executive Officer, K2M
Kristine Peterson, Chief Executive Officer, Valeritas